He H - Search Results

1

MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.

Cheng B, Lai Y, Huang H, Peng S, Tang C, Chen J, Luo T, Wu J, He H, Wang Q, Huang H. Cheng B, et al. Among authors: he h. Environ Toxicol. 2024 Feb;39(2):927-941. doi: 10.1002/tox.23997. Epub 2023 Nov 16. Environ Toxicol. 2024. PMID: 37972062

2

HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma.

Zhou QH, Li KW, Chen X, He HX, Peng SM, Peng SR, Wang Q, Li ZA, Tao YR, Cai WL, Liu RY, Huang H. Zhou QH, et al. Among authors: he hx. J Immunother Cancer. 2020 Jan;8(1):e000157. doi: 10.1136/jitc-2019-000157. J Immunother Cancer. 2020. PMID: 31959726 Free PMC article.

3

TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.

Zhou Q, Chen X, Yao K, Zhang Y, He H, Huang H, Chen H, Peng S, Huang M, Cheng L, Zhang Q, Xie R, Li K, Lin T, Huang H. Zhou Q, et al. Among authors: he h. J Exp Clin Cancer Res. 2023 Aug 5;42(1):195. doi: 10.1186/s13046-023-02764-4. J Exp Clin Cancer Res. 2023. PMID: 37542345 Free PMC article.

4

Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis.

Cheng B, He H, Chen B, Zhou Q, Luo T, Li K, Du T, Huang H. Cheng B, et al. Among authors: he h. Int J Surg. 2024 Mar 18. doi: 10.1097/JS9.0000000000001308. Online ahead of print. Int J Surg. 2024. PMID: 38498388

5

WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.

Zhou Q, Chen X, He H, Peng S, Zhang Y, Zhang J, Cheng L, Liu S, Huang M, Xie R, Lin T, Huang J. Zhou Q, et al. Among authors: he h. Theranostics. 2021 Mar 4;11(10):4809-4824. doi: 10.7150/thno.55814. eCollection 2021. Theranostics. 2021. PMID: 33754029 Free PMC article.

6

High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).

Rong Q, Gao Y, Cai Q, Wang X, Bai B, Ping L, He H, Rao H, Zhang Y, Li Z, Cai Q, Jiang W, Huang H. Rong Q, et al. Among authors: he h. Expert Rev Anticancer Ther. 2021 Jan;21(1):121-127. doi: 10.1080/14737140.2021.1853531. Epub 2021 Jan 4. Expert Rev Anticancer Ther. 2021. PMID: 33397158

7

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.

He HX, Gao Y, Fu JC, Zhou QH, Wang XX, Bai B, Li PF, Huang C, Rong QX, Ping LQ, He YX, Mao JY, Chen X, Huang HQ. He HX, et al. Oncoimmunology. 2021 Apr 7;10(1):1907059. doi: 10.1080/2162402X.2021.1907059. Oncoimmunology. 2021. PMID: 33889438 Free PMC article.

8

CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.

Sun Y, Gao Y, Chen J, Huang L, Deng P, Chen J, Chai KXY, Hong JH, Chan JY, He H, Wang Y, Cheah D, Lim JQ, Chia BKH, Huang D, Liu L, Liu S, Wang X, Teng Y, Pang D, Grigoropoulos NF, Teh BT, Yu Q, Lim ST, Li W, Ong CK, Huang H, Tan J. Sun Y, et al. Among authors: he h. Cancer Lett. 2021 Sep 2;521:268-280. doi: 10.1016/j.canlet.2021.09.002. Online ahead of print. Cancer Lett. 2021. PMID: 34481935 Free article.

9

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

Chen J, Zuo Z, Gao Y, Yao X, Guan P, Wang Y, Li Z, Liu Z, Hong JH, Deng P, Chan JY, Cheah DMZ, Lim J, Chai KXY, Chia BKH, Pang JWL, Koh J, Huang D, He H, Sun Y, Liu L, Liu S, Huang Y, Wang X, You H, Saraf SA, Grigoropoulos NF, Li X, Bei J, Kang T, Lim ST, Teh BT, Huang H, Ong CK, Tan J. Chen J, et al. Among authors: he h. Clin Epigenetics. 2023 Feb 6;15(1):19. doi: 10.1186/s13148-023-01436-6. Clin Epigenetics. 2023. PMID: 36740715 Free PMC article. Clinical Trial.

10

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.

Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W. Li D, et al. Among authors: he h. Sci Adv. 2023 Dec;9(48):eadg9721. doi: 10.1126/sciadv.adg9721. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,916 results

Search Page